Browse the evidence

Prior use of anti-obesity medications (AOMs) does not alter patient motivations for seeking bariatric surgery, as patients prioritize health and longevity regardless of prior pharmaceutical weight loss history.

If you are considering bariatric surgery, your history of using weight loss drugs like Ozempic or Wegovy likely won't change your reasons for wanting surgery. Most patients, regardless of drug history, want surgery to live longer and feel healthier, not just to hit a specific number on the scale. You can still use these drugs after surgery to help you lose even more weight if you are open to it.

Patients who use anti-obesity medications (AOMs) prior to bariatric surgery experience significant weight regain (average 18 kg) upon stopping the medication, yet this history does not negatively impact their expectations for surgical weight loss.

If you stop taking weight loss drugs like Ozempic before surgery, you will likely regain the weight you lost (average 18kg). However, this history does not mean surgery will fail. Your expectations for surgery should remain focused on long-term health, as your prior drug experience doesn't change your surgical goals or likely success.

Age is the most significant factor for multimorbidity, with individuals over 60 years old having a 5.89 times higher likelihood of reporting two or more chronic diseases compared to those under 49.

As you age, the risk of developing multiple chronic conditions increases significantly. However, managing modifiable risk factors like blood pressure and weight can help mitigate this risk. Regular health screenings and adherence to medication for conditions like hypertension and diabetes are crucial for older adults to prevent multimorbidity.

Lower educational attainment is associated with higher prevalence of hypertension and diabetes, although this association becomes less pronounced after adjusting for other socioeconomic and demographic variables.

Education level is linked to health outcomes, with less education correlating with higher rates of hypertension and diabetes. Public health efforts should focus on providing accessible, easy-to-understand health information and care for individuals with lower educational attainment to reduce these disparities.

Weight loss, whether intentional or unintentional, increases serum concentrations of lipophilic persistent organic pollutants (POPs) by releasing them from adipose tissue into circulation, potentially negating long-term cardiovascular benefits of weight loss in type 2 diabetes patients.

For individuals with type 2 diabetes, standard weight loss advice may have hidden costs due to the release of stored environmental pollutants. While weight loss improves short-term markers, it may not reduce long-term heart disease risk if these pollutants are released. Future management may need to consider how to minimize this release or its effects, rather than focusing solely on fat mass reduction.

Bariatric surgery (specifically gastric bypass) leads to net cost savings for healthcare systems, but this economic benefit is conditional on long-term follow-up (typically >17 years) and specific surgical techniques, as short-term costs exceed conservative management.

For healthcare policymakers, bariatric surgery (specifically gastric bypass) should be viewed as a long-term investment rather than a short-term expense. While initial costs exceed conservative management, the break-even point is typically reached after 17 years due to reduced chronic disease burden. For patients, this highlights that the procedure's value is realized over decades, not months.

High-fat diets induce a pro-inflammatory phenotype in neutrophils and their bone marrow progenitors via NLRP3 inflammasome activation and IL-1b signaling, contributing to systemic low-grade inflammation and insulin resistance.

Your immune system is listening to what you eat. Diets high in certain fats can program your white blood cells to stay in a state of low-grade alert, which contributes to insulin resistance and heart disease risk. Choosing healthier fat profiles (like unsaturated fats) may help keep these immune cells from becoming over-activated.

Short-chain fatty acids (SCFAs) like butyrate and acetate have complex, site-specific effects on neutrophils, potentially promoting anti-inflammatory or pro-resolutive functions depending on the context and receptor interaction (e.g., FFAR2).

Fiber-rich foods produce short-chain fatty acids (SCFAs) in your gut, which can have beneficial, anti-inflammatory effects on your immune system. Including fiber in your diet supports these healthy fat-derived signals.

Saturated fatty acids (e.g., palmitate) promote neutrophil extracellular trap (NET) formation and NLRP3 inflammasome activation, whereas unsaturated fatty acids (e.g., oleic, linoleic, omega-3s) tend to inhibit these pro-inflammatory pathways.

The type of fat you eat matters for inflammation. Saturated fats can trigger inflammatory responses in white blood cells, while unsaturated fats (found in olive oil, fish, nuts) can help suppress these responses.

Eating Disorder (ED) diagnosis is significantly associated with amenorrhea in resistance-trained athletes, consistent with Relative Energy Deficiency in Sport (REDs) models.

If you have an eating disorder diagnosis, you are at higher risk for missing periods (amenorrhea). This is a sign of Relative Energy Deficiency in Sport (REDs). Addressing energy availability is crucial for restoring menstrual function and long-term health.

Higher levels of the satiety hormone GLP-1 are associated with lower salt taste preference specifically following a low-fat diet.

When eating a low-fat diet, higher levels of the gut hormone GLP-1 are associated with a lower preference for salty foods. This suggests that GLP-1 may play a role in modulating salt taste preferences specifically in the context of low-fat eating.

Maintaining serum Lipoprotein(a) [Lp(a)] levels below 298 mg/L is associated with a delay in the progression of coronary artery disease severity.

If you have heart disease, ask your doctor to check your Lipoprotein(a) level. The study suggests keeping it below 298 mg/L. Unlike other cholesterol markers, Lp(a) is largely genetic and doesn't drop significantly with diet or exercise alone, so you may need specific medical therapies to manage it.

Obesity pathogenesis is driven by a complex network of 802 core genetic risk genes that function through integrated neurological (appetite regulation, synaptic signaling) and metabolic (lipid/glucose homeostasis) pathways.

Obesity is not just a lifestyle choice; it is heavily influenced by your genetics. If you have a family history of obesity, your body may regulate appetite and metabolism differently. This doesn't mean you can't lose weight, but it means you may need more targeted strategies, such as medical interventions that address specific hormonal pathways (like GLP-1 or MC4R agonists), rather than relying on standard diet advice alone.

Obesity-risk genes are highly expressed in specific cell types: hypothalamic neurons (regulating appetite), pancreatic beta-cells (regulating insulin), adipocytes (lipid homeostasis), and hepatocytes (lipid metabolism).

Obesity affects multiple organs. Your brain (hypothalamus) controls hunger, your pancreas controls insulin, your fat cells store energy, and your liver processes fats. Effective treatment often needs to address these specific tissues, which is why drugs like GLP-1 agonists (which act on the brain and pancreas) are effective.

Obesity is associated with an 'obesity paradox' in end-stage renal disease, where higher BMI may correlate with lower mortality in dialysis patients, potentially due to greater muscle mass or nutritional reserves.

While obesity increases the risk of developing kidney disease, some studies show that obese patients on dialysis may live longer than thin patients. This 'obesity paradox' might be because they have more muscle mass or nutritional reserves to fight illness. However, preventing kidney disease by maintaining a healthy weight is still the best strategy.

Higher socioeconomic status (income and education) is associated with higher recognition of nutrition labels, yet this recognition does not necessarily translate to actual usage or improved dietary intake, particularly in elderly and low-education populations.

Knowing a label exists isn't enough; you must be able to read and use it. If you are older or have less formal education, standard back-of-package labels may be too complex. Advocate for or look for front-of-pack 'at-a-glance' labels (like warning labels or traffic lights) which are easier to process quickly. Recognition of labels correlates with higher income and education, so be aware that these tools may be less effective for you without additional education on how to interpret them.

Self-reported macronutrient intake (fat, carbs, protein, sugar) is not consistently associated with future hypothalamic gliosis in humans.

Unlike in animal studies, simply changing your macronutrient ratios (fat, carbs, protein) doesn't seem to predict brain inflammation in humans. Focus on overall metabolic health rather than obsessing over specific macronutrient percentages for brain health.

Financial policy measures, such as fiscal interventions, are required to effectively reduce meat consumption, as individual voluntary changes alone are insufficient.

Support policies that make healthy, sustainable food more affordable and accessible. Individual efforts are important, but systemic change through policy is necessary for widespread impact.

Among Malaysian reproductive-age women (35-49 years), dietary intakes of calcium, magnesium, phosphorus, vitamin K, and vitamin C are not significantly associated with the risk of bone fractures.

For women aged 35-49, ensuring high intake of calcium, magnesium, phosphorus, vitamin K, and C does not appear to statistically lower fracture risk in this population, according to this study. Instead, managing diabetes and avoiding passive smoking are more critical factors for bone health. Focus on overall health management rather than just micronutrient supplementation for fracture prevention.

In Malaysian reproductive-age women, diabetes mellitus and passive smoking are significant predictors of bone fractures, whereas active smoking and physical activity levels are not.

For women aged 35-49, avoiding exposure to secondhand smoke is crucial for bone health, potentially more so than avoiding active smoking. Managing diabetes is also critical, as it significantly increases fracture risk. These factors outweigh micronutrient intake levels in predicting fractures.

Ultra-processed foods drive obesity primarily through rapid digestion of carbohydrates leading to metabolic swings and hunger, not through hyper-palatability or tastiness.

Focus on the metabolic impact of food processing rather than just taste. Choose minimally processed foods where the food matrix slows digestion (like whole fruits vs. sugar, or wheat berries vs. white bread). This helps stabilize blood glucose and insulin, reducing the hunger signals that drive overconsumption, regardless of how 'tasty' the food is.

Endoscopic Bariatric Therapies (EBTs) such as ESG and intragastric balloons are largely unknown to patients, with 78.2% unaware of their existence as weight loss options.

Most patients do not know that endoscopic weight loss procedures (like ESG or balloons) exist. If you are seeking weight loss, ask your provider about all options, including endoscopic therapies, as they may not be discussed unless you ask.

Long-term use of inhaled corticosteroids (ICS) with standard-sized particles increases the risk of developing OSA due to pharyngeal muscle atrophy and neck fat redistribution, whereas extra-fine particles do not show this increased risk.

If you use standard inhaled corticosteroids and have sleep apnea, ask your doctor about switching to extra-fine particle formulations. These may reduce the risk of worsening sleep apnea while still controlling your asthma, as they deposit deeper in the lungs rather than the throat.

A multidisciplinary care model involving plastic surgeons, bariatric specialists, dieticians, and mental health providers is essential for optimizing safety and outcomes in body contouring surgery for massive weight loss patients.

If you are considering body contouring after significant weight loss, ensure your care team includes not just a surgeon, but also a dietitian to check for nutrient deficiencies, a mental health professional to manage expectations, and a primary care doctor to manage conditions like diabetes. This coordinated approach minimizes complications and improves long-term satisfaction.